Researchers have isolated a new SARS-CoV-2 Omicron subvariant, BA.2.86, revealing its ability to escape neutralizing antibodies five-fold greater than its ancestor strain. Despite its enhanced immune evasion capabilities, BA.2.86 has not shown a significant difference in spread compared to other current variants.
Opinion | Hospitalization Should Not Mean Financial Ruin for Medicare Beneficiaries
Chatterjee is a physician, health policy researcher, and an assistant professor of medicine. Macneal is a statistical analyst. Patel is a senior research coordinator. Medicare
December 9, 2024